Teva Pharmaceutical Industries Ltd SEC filings TEVA
Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 11, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Change to shareholder rights
|
Sep 3, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 11, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2024 | Jun 23, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 31, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 28, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 24, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 8, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Officer or director change
|
May 11, 2023 | May 8, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 3, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2023 | Feb 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 26, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 24, 2021 | Nov 22, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 10, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Other events
|
Nov 2, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2021 | Aug 26, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2021 | Jul 2, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2021 | Jan 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2021 | Jan 21, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2020 | Aug 4, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 25, 2019 | Nov 25, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2019 | Oct 21, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2019 | Oct 2, 2019 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2019 | Jun 11, 2019 |
| 8-K |
Current report
Results of operations
|
May 2, 2019 | May 2, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 10, 2019 | Apr 8, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2019 | Feb 13, 2019 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 14, 2018 | Dec 14, 2018 |
| 8-K |
Current report
Change to shareholder rights
|
Dec 4, 2018 | Dec 4, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 26, 2018 | Nov 26, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2018 | Nov 1, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2018 | Aug 2, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2018 | Jun 5, 2018 |
| 8-K |
Current report
Results of operations
|
May 3, 2018 | May 3, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2018 | Apr 27, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 14, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2018 | Feb 8, 2018 |
| 8-K |
Current report
Material agreement
|
Feb 1, 2018 | Feb 1, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 1, 2018 | Feb 1, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2018 | Jan 4, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2018 | Jan 2, 2018 |
| 6-K | Current report (foreign issuer) | Dec 27, 2017 | Dec 27, 2017 |
| 6-K | Current report (foreign issuer) | Dec 18, 2017 | Dec 18, 2017 |
| 6-K | Current report (foreign issuer) | Dec 15, 2017 | Dec 15, 2017 |
| 6-K | Current report (foreign issuer) | Dec 14, 2017 | Dec 14, 2017 |
| 6-K | Current report (foreign issuer) | Dec 13, 2017 | Dec 13, 2017 |
| 6-K | Current report (foreign issuer) | Dec 12, 2017 | Dec 12, 2017 |
| 6-K | Current report (foreign issuer) | Dec 11, 2017 | Dec 11, 2017 |
| 6-K | Current report (foreign issuer) | Nov 29, 2017 | Nov 29, 2017 |
| 6-K | Current report (foreign issuer) | Nov 27, 2017 | Nov 27, 2017 |
| 6-K | Current report (foreign issuer) | Nov 2, 2017 | Nov 2, 2017 |
| 6-K | Current report (foreign issuer) | Nov 2, 2017 | Nov 2, 2017 |
| 6-K | Current report (foreign issuer) | Nov 2, 2017 | Nov 2, 2017 |
| 6-K | Current report (foreign issuer) | Nov 1, 2017 | Nov 1, 2017 |
| 6-K | Current report (foreign issuer) | Oct 31, 2017 | Oct 31, 2017 |
| 6-K | Current report (foreign issuer) | Oct 30, 2017 | Oct 30, 2017 |
| 6-K | Current report (foreign issuer) | Oct 26, 2017 | Oct 26, 2017 |
| 6-K | Current report (foreign issuer) | Oct 19, 2017 | Oct 19, 2017 |
| 6-K | Current report (foreign issuer) | Oct 17, 2017 | Oct 17, 2017 |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TEVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Large accelerated filer
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.